Pierre Dodion, Md, Mba
Executive Vice President, Research and Development
immunology
pharma
Rwanda
Biography
Pierre Dodion joined Innate Pharma in September 2014. He has 25 years of experience in Medical affairs in the pharmaceutical industry having worked at Pfizer (2006-2008), Novartis (2002-2006) and Aventis (1996-2002). He contributed to the development, approval and launch of several drugs, including sunitinib (Sutent®, kidney cancer and GIST) and letrozole (Femara®, breast cancer).
Research Interest
Pierre Dodion joined Innate Pharma in September 2014. He has 25 years of experience in Medical affairs in the pharmaceutical industry having worked at Pfizer (2006-2008), Novartis (2002-2006) and Aventis (1996-2002). He contributed to the development, approval and launch of several drugs, including sunitinib (Sutent®, kidney cancer and GIST) and letrozole (Femara®, breast cancer).
